“…Moreover, LILRAs have been demonstrated to play important roles in infection or autoimmune diseases such as HIV infection [ 11 ], multiple sclerosis [ 12 ], atopic dermatitis [ 13 ] and rheumatoid arthritis [ 14 ]. It has been reported that LILRA1, 3, 4 and 5 bind with HLA-G, HLA-C and classical HLAs [ 3 , 7 , 11 , 13 , 14 ] and regulate adaptive or innate immune pathways such as the ERK/MEK [ 15 ], TLR [ 3 ] and JNK/p38MAPK [ 16 ] signaling pathways. Additionally, they have been reported to upregulate the cytokines IL-1R, IL-4, IL-6, IL-10, IL-12, IL-17, TNFα and IFN-γ [ 3 , 7 , 11 , 14 ].…”